Actuate Therapeutics Inc (ACTU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Actuate Therapeutics Inc

    NASDAQ: ACTU · Real-Time Price · USD
    6.98
    0.29 (4.33%)
    At close: Oct 03, 2025, 3:59 PM
    6.98
    0.00%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    Actuate Therapeutics Inc Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
    Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Income
    		 -5.97M -6.37M -6.56M -5.39M -5.44M -7.77M -7.62M -6.48M -5.58M -5.3M
    Interest Income
    		 24.53K 53.62K 118.11K 80.75K 8.64K 14.79K 59.69K 125.94K 115.39K n/a
    Pretax Income
    		 -5.95M -6.32M -6.45M -5.97M -6.57M -8.3M -7.61M -6.34M -5.52M -5.27M
    Net Income
    		 -5.95M -6.32M -6.45M -5.97M -6.57M -8.3M -7.61M -6.34M -5.52M -5.27M
    Selling & General & Admin
    		 3.2M 3.15M 2.87M 1.64M 1.06M 912.82K 969.35K 714.17K 807.18K 774.8K
    Research & Development
    		 2.76M 3.22M 3.69M 3.76M 4.37M 6.86M 6.65M 5.76M 4.78M 4.52M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a -0.00 n/a
    Operating Expenses
    		 5.97M 6.37M 6.56M 5.39M 5.44M 7.77M 7.62M 6.48M 5.58M 5.3M
    Interest Expense
    		 5.06K 5.06K 5.08K 3.49K 5.08K 5.08K 5.06K 5.06K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 5.97M 6.37M 6.56M 5.39M 5.44M 7.77M 7.62M 6.48M 5.58M 5.3M
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 19.65M 19.5M 10.77M 10.77M 19.53M 15.49M 15.26M 15.49M 14.22M 13.39M
    Shares Outstanding (Diluted)
    		 19.65M 19.5M 10.77M 10.77M 19.53M 15.49M 15.26M 15.49M 14.22M 13.4M
    EPS (Basic)
    		 -0.3 -0.32 -0.6 -0.55 -0.34 -0.54 -0.5 -0.41 -0.39 -0.39
    EPS (Diluted)
    		 -0.3 -0.32 -0.6 -0.55 -0.34 -0.54 -0.5 -0.41 -0.39 -0.39
    EBITDA
    		 -5.94M -6.37M -6.44M -5.97M -6.57M -8.29M -7.61M -6.33M n/a n/a
    EBIT
    		 -5.94M -6.31M -6.44M -5.97M -6.57M -8.29M -7.61M -6.33M -5.58M -5.3M
    Depreciation & Amortization
    		 n/a 6.37M 118.11K -574.57K -1.13M -517.73K 8.09K 142.81K 5.58M 5.3M

    Add to Watchlist